AC
HIMS icon

Armistice Capital’s Hims & Hers Health HIMS Stock Holding History

Armistice Capital’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,862
Closed -$555K – 310
2024
Q1 		$555K Buy
+35,862
New +$404K 0.01% 190

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital's HIMS Position: Q2 2024 in Review

Armistice Capital sold out of Hims & Hers Health (HIMS) in Q2 2024, closing a stake of 35,862 shares — an estimated $555K sold.

Armistice Capital first reported a position in HIMS in Q1 2024 and held it in 1 quarter. The position peaked at $555K in Q1 2024. 297 funds tracked by Wall St. Rank hold HIMS as of Q2 2024.

  • Armistice Capital reported no remaining Hims & Hers Health position as of Q2 2024 after selling out during the quarter.
  • Armistice Capital sold 35,862 Hims & Hers Health shares in Q2 2024, an estimated $555K.
  • Armistice Capital first reported a position in Hims & Hers Health in Q1 2024 and held it in 1 quarter.
  • Armistice Capital's Hims & Hers Health position peaked at $555K in Q1 2024.
  • 297 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.